Safety, tolerability, and pharmacodynamics of an anti-interleukin-1 alpha/beta dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study Article

Wang, S. X., Abramson, S. B., Attur, M. et al. (2017). Safety, tolerability, and pharmacodynamics of an anti-interleukin-1 alpha/beta dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study . OSTEOARTHRITIS AND CARTILAGE, 25(12), 10.1016/j.joca.2017.09.007



Industry Collaboration International Collaboration

cited authors

  • Wang, S. X.; Abramson, S. B.; Attur, M.; Karsdal, M. A.; Preston, R. A.; Lozada, C. J.; Kosloski, M. P.; Hong, F.; Jiang, P.; Saltarelli, M. J.; Hendrickson, B. A.; Medema, J. K.

publication date

  • December 2017

published in

author keyword

category

Digital Object Identifier (DOI)

volume

  • 25

issue

  • 12

research area